Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
基本信息
- 批准号:7786750
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-10-01 至 2013-09-30
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAddressAftercareAmerican Lung AssociationAttentionBehavior TherapyBehavioralBiologicalBupropionCarbon MonoxideCategoriesCessation of lifeCharacteristicsCigaretteClinicClinical Practice GuidelineCocaineCognitiveCommunitiesDepartment of DefenseDiabetes MellitusDiagnosticDisabled PersonsDiseaseDrug usageEducationEffectivenessEnsureFaceFundingGeneral PopulationGoalsGrantGuidelinesHealthHealth Care CostsHealth care facilityHealthcareHealthcare SystemsHeart DiseasesHeroinImpairmentInterventionLifeMalignant neoplasm of lungMarylandMeasuresMedical EconomicsMental HealthMental disordersModelingMorbidity - disease rateNational Institute of Drug AbuseNicotine DependenceObesityOutcomeParticipantPatient Self-ReportPatientsPersonsPharmacotherapyPhasePoliciesPopulationProceduresPublic HealthRandomizedRandomized Clinical TrialsReadinessRecruitment ActivityReportingResearchSchizophreniaSeriesSeveritiesSmokeSmokerSmokingSmoking Cessation InterventionSocial supportSpecific qualifier valueSubstance AddictionSubstance Use DisorderSubstance abuse problemTechnologyTestingTobacco useUnited StatesUnited States Agency for Healthcare Research and QualityVeteransWithholding TreatmentWorkabstractingaddictionbasecigarette smokingcontingency managementcostdesignevidence basefollow-uphandicapping conditionhealth care qualityimprovedinnovationmeetingsmortalitynicotine replacementnovel strategiesoutreachprogramspsychologicpublic health relevancerandomized trialsmoking cessationsocialsocial modelsubstance abusertherapy developmenttooltreatment programtrial comparing
项目摘要
DESCRIPTION (provided by applicant):
Abstract Over 70% of people with serious and persistent mental illnesses (SPMI) smoke cigarettes. We have found that delivery of the 5 As of smoking cessation (Ask, Advise, Assess, Assist, Arrange) to persons with SPMI, a practice required by the VA, produces modest reductions in smoking and some increased use of smoking cessation aids, but does not increase abstinence. Existing "best practices" for smoking cessation in SPMI produce low short-term abstinence rates and almost no sustained abstinence. A new approach is needed that is designed for persons with SPMI and utilizes all available strategies for addiction treatment. We have developed an intervention called "Behavioral Treatment of Smoking Cessation in SPMI" (BTSCS), an innovative program that supplements pharmacotherapy and education with contingency management and a multifaceted behavioral group treatment that addresses the cognitive, motivational, and social support problems characteristic of people with SPMI. We propose to conduct a randomized trial of BTSCS compared to a manualized standard cessation program (StSST) that reflects current best practices. BTSCS was modeled after a successful program (Behavioral Treatment of Substance Abuse in SPMI) created by the study team that was designed for people with dual disorders. Hypotheses: We hypothesize that BTSCS will be more effective than StSST in producing and sustaining abstinence as measured by self report and expired CO levels. Subject Population: We will recruit 210 people with SPMI who smoke at least 10 cigarettes per day from the VA Maryland Healthcare System. We expect to randomize 178 people. Procedures: Participants in both conditions will receive brief outreach. Research assessments will be completed at baseline, 3 months (end of treatment), and 3- and 6- month follow ups. Potential Impact on Veterans' Health Care: The VA has recognized the high medical, economic, and social costs of smoking with directives to ensure that veterans are offered cessation programs. Testing an innovative smoking cessation treatment for persons with SPMI is highly significant for the VA because: (1) the rates of smoking among veterans are higher that the general population; (2) smoking rates among persons with SPMI are higher still, and; (3) there are virtually no smoking cessation treatments for veterans with SPMI that are effective in producing abstinence.
PUBLIC HEALTH RELEVANCE:
Project Narrative Despite widespread recognition of the devastating health effects of smoking and the extraordinarily high rates of smoking in people SMI, smoking in SMI has not received the full and urgent attention that it deserves. Given the elevated rates of smoking among patients with SMI, our efforts to test an innovative, broad-based smoking cessation program that is tailored to the needs of this multi-handicapped population carry significant cost, health, and quality of care implications. Integration of smoking cessation within the context of mental health treatment will also provide a new context for addressing nicotine addiction, further enhancing the public health significance of the research.
描述(由申请人提供):
摘要超过70%的患有严重和持续性精神疾病的人(SPMI)抽烟。我们发现,戒烟(询问,建议,评估,协助,安排)的5种交付给有SPMI(VA所要求的做法)的人会减少吸烟,并增加了戒烟辅助工具的使用,但不会增加禁欲。 SPMI戒烟的现有“最佳实践”会产生低短期禁欲率,几乎没有持续的禁欲。需要一种新的方法,该方法是为SPMI的人设计的,并利用所有可用的策略进行成瘾治疗。我们已经开发了一种称为“ SPMI中戒烟的行为治疗”(BTSCS)的干预措施,该计划是一种创新的计划,该计划将药物治疗和教育补充了应急管理以及多方面的行为群体治疗,以解决人们对SPMI的认知,动机和社会支持问题的解决方案。我们建议与反映当前最佳实践的手动标准戒烟计划(STSST)相比,进行BTSC的随机试验。 BTSC是由研究团队创建的成功计划(SPMI中的药物滥用行为治疗)建模的,该计划是专为双重疾病的人设计的。假设:我们假设BTSC在通过自报告和过期的CO水平衡量的产生和维持戒酒方面比STSST更有效。主题人群:我们将招募210名SPMI的人,他们每天从VA Maryland Healthcare系统中吸烟至少10支香烟。我们希望将178人随机分配。程序:两种情况下的参与者都将获得简短的外展。研究评估将在基线,3个月(治疗结束)以及3个月和6个月的随访中完成。对退伍军人的医疗保健的潜在影响:弗吉尼亚州已经认识到使用指令吸烟的高医疗,经济和社会成本,以确保提供退伍军人的戒烟计划。对于VA,对SPMI患者进行创新的戒烟治疗测试是非常重要的,因为:(1)退伍军人中吸烟的速度比一般人群高; (2)SPMI患者的吸烟率更高,并且; (3)几乎没有对SPMI的退伍军人有效产生禁欲的戒烟治疗方法。
公共卫生相关性:
项目叙事尽管广泛认识到吸烟的毁灭性健康影响以及SMI的吸烟率极高,但SMI的吸烟尚未得到应有的全部和紧急关注。鉴于SMI患者的吸烟率升高,我们为测试创新的,基于广泛的吸烟计划的努力量身定制,该计划是根据此多障碍人群的需求量身定制的,具有巨大的成本,健康和护理质量的影响。在心理健康治疗背景下戒烟的整合还将为解决尼古丁成瘾的新背景提供新的背景,从而进一步增强了研究的公共健康意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LISA B. DIXON其他文献
LISA B. DIXON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LISA B. DIXON', 18)}}的其他基金
Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
检查抗精神病药物共同决策干预的有效性,以提高早期精神病患者的治疗参与度
- 批准号:
10670896 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
检查抗精神病药物共同决策干预的有效性,以提高早期精神病患者的治疗参与度
- 批准号:
10510009 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Optimizing Disability Benefit Decisions and Outcomes in First Episode Psychosis
优化首发精神病中的残疾福利决策和结果
- 批准号:
10521916 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Adapting Coordinated Specialty Care in the Post COVID-19 Era
在后 COVID-19 时代调整协调专业护理
- 批准号:
10193474 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Zero Suicide Implementation and Evaluation in Outpatient Mental Health Clinics
门诊心理健康诊所零自杀实施与评估
- 批准号:
10572128 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Improving Life Trajectories for Youth with Early Psychosis
改善早期精神病青少年的生活轨迹
- 批准号:
8916281 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
- 批准号:
8195952 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
- 批准号:
8392115 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
- 批准号:
7916627 - 财政年份:2009
- 资助金额:
-- - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
- 批准号:
10546293 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Modular Virtual Reality Therapeutic for Opioid and Stimulant Use Disorders
针对阿片类药物和兴奋剂使用障碍的模块化虚拟现实治疗
- 批准号:
10784642 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Long-acting injectable ketamine for improved substance use disorder (SUD) treatment without dissociative effects.
长效注射氯胺酮,用于改善物质使用障碍 (SUD) 治疗,且不会产生解离效应。
- 批准号:
10744308 - 财政年份:2023
- 资助金额:
-- - 项目类别: